Summary
- Current Price
- As of today, GPCR price is $53.75, down -1.52% on
- Current Price All-Time High
- GPCR price is currently -43.36% below its historical high of $94.90 set on
- Market Cap
- GPCR current market cap is $4B, up +224.57% over the past 365 days
- PE Ratio
- GPCR PE ratio is unknown
- Revenue
- GPCR current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- The next earnings release for GPCR is on
Profile
| Metric | Value |
|---|---|
| Full Name | Structure Therapeutics Inc. |
| Ticker | NASDAQ: GPCR |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | structuretx.com |
| Employees | 183 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $53.75 | |
| Price, 1D Change | -1.52% | |
| $4B | ||
| - | ||
| - | ||
| 0.71 | ||
| $0 | ||
| Revenue, 1Y Change | 0.00% | |
| -$2.39 | ||
| EPS, 1Y Change | -2.70% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$2.39 | ||
| EPS Estimate | N/A | -$1.44 |
| EPS Est. Change | N/A | +40.00% |
| $0.00 | ||
| Revenue Estimate | N/A | $60.00M |
| Revenue Est. Change | N/A | - |
| Current Price | $53.75 | |
| Price Target | - | $105.00 |
| Price Tgt. Change | - | +95.35% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.76 | -$2.33 | -205.52% | |
| -$1.37 | -$2.39 | -74.33% | |
| -$1.44 | N/A | +40.00% | |
| -$2.13 | N/A | +11.04% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| $60.00M | N/A | - | |
| $55.56K | N/A | - |
🔒 Log In To Unlock Full Data
Performance
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $53.75 | |
| $39.84 | ||
| SMA 200 vs Price | -25.88% | |
| $73.04 | ||
| SMA 50 vs Price | +35.89% | |
| 0.71 | ||
| $3.76 | ||
| 25.71 | ||
| 44.79% | ||
| 123.26% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| -$2.39 | ||
| $0.00 | ||
| - | ||
| -$287.57M | ||
| - | ||
| -$141.58M | ||
| - | ||
| -$283.67M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.00 | ||
| 24.81 | ||
| 24.81 | ||
| - | ||
| - | ||
| 34.46 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| 2.50 | ||
| -8.31 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $1.52B | ||
| $1.45B | ||
| $1.58B | ||
| $1.57B | ||
| $67.54M | ||
| $63.29M | ||
| $6.49M | ||
| $2.88M | ||
| $13.86M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $141.58M | ||
| $283.67M | ||
| $3.90M | ||
| $0.00 | ||
| $3.90M | ||
| $0.00 | ||
| $516.40K |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$222.79M | ||
| $90.03M | ||
| $764.53M | ||
| $3.62M | ||
| -$226.41M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| HC Wainwright & Co. | → | |
| Citizens | → | |
| JP Morgan | → | |
| Guggenheim | → | |
| HC Wainwright & Co. | → | |
| Morgan Stanley | → | |
| Citizens | → | |
| Jefferies | → | |
| Stifel | → | |
| Clear Street | → |
Analyst sentiment
Institutional ownership
Screeners with GPCR
FAQ
What is the ticker symbol for Structure Therapeutics Inc.?
The ticker symbol for Structure Therapeutics Inc. is NASDAQ:GPCR
Does Structure Therapeutics Inc. pay dividends?
No, Structure Therapeutics Inc. does not pay dividends
What sector is Structure Therapeutics Inc. in?
Structure Therapeutics Inc. is in the Healthcare sector
What industry is Structure Therapeutics Inc. in?
Structure Therapeutics Inc. is in the Biotechnology industry
What country is Structure Therapeutics Inc. based in?
Structure Therapeutics Inc. is headquartered in United States
When did Structure Therapeutics Inc. go public?
Structure Therapeutics Inc. initial public offering (IPO) was on February 3, 2023
Is Structure Therapeutics Inc. in the S&P 500?
No, Structure Therapeutics Inc. is not included in the S&P 500 index
Is Structure Therapeutics Inc. in the NASDAQ 100?
No, Structure Therapeutics Inc. is not included in the NASDAQ 100 index
Is Structure Therapeutics Inc. in the Dow Jones?
No, Structure Therapeutics Inc. is not included in the Dow Jones index
When was Structure Therapeutics Inc. last earnings report?
Structure Therapeutics Inc.'s most recent earnings report was on February 26, 2026
When does Structure Therapeutics Inc. report earnings?
The next expected earnings date for Structure Therapeutics Inc. is May 7, 2026
Data Sources & References
- GPCR Official Website structuretx.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1888886/000110465926020562/0001104659-26-020562-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1888886/000110465926020562/0001104659-26-020562-index.htm
- GPCR Profile on Yahoo Finance finance.yahoo.com/quote/GPCR
- GPCR Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/gpcr